The ‘I Know My Patients’ Myth: Lessons from the Lynn G v Hugo Case

Lynn G v Hugo is a case with huge implications, yet it has largely gone unnoticed. Practitioners remain unaware of it, despite the fact that it dismantles some of the very assumptions they tend to rely on. "I know my patient, I would have picked up on it." People have a tendency to think "this could never happen to me"- until it does. 

Dr Norman Hugo presumably felt the same way about Mrs Lynn G, a woman in her early forties, married to a successful businessman, living in the affluent Upper East Side of New York. She had come to him after he performed her daughter's rhinoplasty. Over the next seven years, she saw Dr Hugo more than 50 times for consultations and cosmetic treatments including eyelid surgery, facial liposuction, and wrinkle-smoothing treatments.

None of her requests seemed unreasonable. Dr Hugo presumably saw no concerning signs. She was a long-term patient, satisfied with her results, who kept coming back to a surgeon she trusted. Exactly the kind of relationship practitioners point to when they say they would sense if something felt off.

It is worth noting that Dr Norman Hugo was not a fringe practitioner or lightly trained injector. He was a prominent Manhattan plastic surgeon, chief of plastic surgery at Columbia-Presbyterian, a past president of the American Society of Plastic Surgeons, and a frequent contributor to medical journals throughout his career. Exactly the kind of practitioner one would assume had seen it all and could handle whatever came his way.

After multiple successful treatments, Lynn G decided to address a "pouch-like" stomach with liposuction in February 1993. When this did not produce the result she wanted, she underwent a full abdominoplasty nine months later in November 1993. Afterwards, she complained of an unsightly abdominal scar, a risk that had been discussed with her before the procedure. She continued to see Dr Hugo for post-op reviews and unrelated procedures through February 1994. Then, seemingly out of nowhere, came a lawsuit: medical malpractice and lack of informed consent.

You would expect that to be dismissed quickly. Nothing about the procedure or its outcome was out of the ordinary. Dr Hugo had discussed the risks, including scarring, obtained a signed consent, and Lynn G had even written "I understand" in her own hand on her hospital chart.

Her basis for legal action? She claimed to be affected by Body Dysmorphic Disorder.

Body Dysmorphic Disorder, or BDD, is a mental health condition centred on an intense preoccupation with perceived flaws in appearance, often flaws that others would barely notice or not see at all. It can distort a patient's perception of their own appearance severely enough that their ability to provide valid informed consent becomes genuinely questionable.

Lynn G argued that Dr Hugo should have recognised signs that she was suffering from BDD and referred her for psychiatric evaluation before proceeding. She pointed to her history of repeated cosmetic procedures and the fact that the surgeon knew she was taking antidepressant medication as warning signs that should have prompted concern.

After 6 years of litigation, the New York Court of Appeals eventually sided with Dr Hugo in 2001, but that could hardly be called a win. Legal outcome and claim cost are not the same thing; there are defence expenses, time, disrupted operations, reputational damage, and the mental toll of being taken to court. In a real sense, Dr Hugo lost the moment the claim made it that far.

Yet, Dr Hugo got relatively lucky. His meticulous documentation was one of the things that protected him, but circumstances also played a role. Lynn G's psychiatrist,  Dr. Gerald Freiman, died shortly before deposition, and her medical records disappeared in an office burglary (interestingly, this  was never confirmed by any police record). Without sufficient evidence that she had in fact suffered from BDD at the relevant time, her case could not hold.

Did Lynn G actually have BDD? We don't know, and in hindsight it is not the point. Even if she did, Dr Hugo could not reasonably have been expected to identify it. Multiple cosmetic procedures are not necessarily a red flag. Persistent dissatisfaction often is, but a patient can be satisfied with one outcome only for the preoccupation to shift to another feature. 

BDD is difficult to diagnose even in clinical settings, and practically impossible to identify in cosmetic practice. Patients have a strong incentive to conceal distress if they believe it may prevent them from getting the procedure they want. Psychological screening questionnaires do not work in these settings- their self-report nature makes them unfit for purpose in cosmetic context, not to mention practitioners are not adequately qualified to interpret them. “Ruling out” psychological issues (beyond “obvious” distress) is not a clean or realistic burden to put on cosmetic practitioners.

What Lynn G v Hugo reveals about false reassurance in cosmetic practice

Lynn G v Hugo should be a humbling reality check for the whole aesthetic medicine industry. It contains every theme that tends to give practitioners a false sense of security: a well-established cosmetic doctor with institutional clout, a long-term patient, repeat visits, satisfaction with multiple prior treatments, no obvious rupture in the relationship, and then suddenly a dispute that expanded far beyond an unsatisfactory aesthetic outcome into a question of whether the patient was ever psychologically suitable to proceed at all.

[Cosmetic practitioners] should not be held responsible for psychological unsuitability they had no means of detecting. But that protection only holds if they took reasonable measures to ensure the patient was genuinely informed.

The uncomfortable truth this case exposes is that a strong patient-practitioner relationship is not a safeguard. Years of familiarity are not a safeguard. Decades of experience and practice is not a safeguard. Determining whether a patient is psychologically suitable for treatment is beyond the limits of cosmetic practice, and pretending otherwise is where the real risk lies.

Twenty-five years on, there is still no consensus on how to handle this. Screening does not work. What the industry has not addressed is the gap in disclosure. Patients are routinely informed about physical risks before they proceed. The psychological risks, including the possibility that a condition like BDD may mean they are unlikely to benefit from the outcome they are seeking, are rarely disclosed in any structured or consistent way.

Just as a practitioner cannot be held responsible for an unknown allergy or an unpredictable physical complication, they should not be held responsible for psychological unsuitability they had no means of detecting. But that protection only holds if they took reasonable measures to ensure the patient was genuinely informed. Documented, consistent disclosure of psychological risks is not a screening tool. It is the disclosure standard the industry does not yet have.